EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieMultizentrische StudieOpen Access

The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial

Matthew T Menard, Alik Farber, Gheorghe Doros, Katherine L McGinigle, Emiliano Chisci, Leonardo C Clavijo, Ahmed Kayssi, Peter A Schneider, Beau M Hawkins, Michael D Dake, Taye Hamza, Michael B Strong und 2 weitere

Journal of Vascular Surgery · 2024

DOI: 10.1016/j.jvs.2024.07.085 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Vascular Surgery, 2024. Verfasst von Matthew T Menard und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: mmenard@bwh.harv…. Hauptthemen laut MEDLINE: Hemodynamics, Endovascular Procedures, Recurrence, Peripheral Arterial Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health, National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Sustained clinical and hemodynamic benefit after revascularization for chronic limb-threatening ischemia (CLTI) is needed to resolve symptoms and prevent limb loss. We sought to compare rates of clinical and hemodynamic failure as well as resolution of initial and prevention of recurrent CLTI after endovascular (ENDO) vs bypass (OPEN) revascularization in the Best-Endovascular-versus-best-Surgical-Therapy-in-patients-with-CLTI (BEST-CLI) trial. METHODS: As planned secondary analyses of the BEST-CLI trial, we examined the rates of (1) clinical failure (a composite of all-cause death, above-ankle amputation, major reintervention, and degradation of WIfI stage); (2) hemodynamic failure (a composite of above-ankle amputation, major and minor reintervention to maintain index limb patency, failure to an initial increase or a subsequent decrease in ankle brachial index of 0.15 or toe brachial index of 0.10, and radiographic evidence of treatment stenosis or occlusion); (3) time to resolution of presenting CLTI symptoms; and (4) incidence of recurrent CLTI. Time-to-event analyses were performed by intention-to-treat assignment in both trial cohorts (cohort 1: suitable single segment great saphenous vein [SSGSV], N = 1434; cohort 2: lacking suitable SSGSV, N = 396), and multivariate stratified Cox regression models were created. RESULTS: In cohort 1, there was a significant difference in time to clinical failure (log-rank P 80 years, WIfI stage, tissue loss, and infrapopliteal disease). Factors independently associated with clinical failure included age >80 years in cohort 1 and ESRD across both cohorts. ESRD was associated with hemodynamic failure in cohort 1. Factors associated with slower resolution of presenting symptoms included diabetes in cohort 1 and WIfI stage in cohort 2. CONCLUSIONS: Durable clinical and hemodynamic benefit after revascularization for CLTI is important to avoid persistent and recurrent CLTI, reinterventions, and limb loss. When compared with ENDO, initial treatment with OPEN surgical bypass, particularly with available saphenous vein, is associated with improved clinical and hemodynamic outcomes and enhanced resolution of CLTI symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemodynamicsEndovascular ProceduresRecurrencePeripheral Arterial DiseaseTreatment FailureAmputation, SurgicalVascular PatencyHumansMaleFemaleAgedTime FactorsRisk FactorsMiddle AgedLimb SalvageChronic Limb-Threatening IschemiaIschemiaAnkle Brachial IndexChronic DiseaseVascular GraftingProportional Hazards Models

Stichwörter der Autor:innen

Critical limb-threatening ischemiaEndovascularHemodynamicPeripheral artery diseaseRevascularizationSurgical bypassWIfIWound healing

Autor:innen und Institutionen

  • Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: mmenard@bwh.harvard.edu.
  • Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
  • School of Public Health, Boston University, Boston, MA.
  • Division of Vascular Surgery, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Department of Surgery, Vascular Surgery Division, San Giovanni di Dio Hospital, Florence, Italy.
  • Coastal Cardiology, French Hospital Medical Center, San Luis Obispo, CA.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health
  • National Heart Lung and Blood Institute

Zitieren

APA

Menard, M. T., Farber, A., Doros, G., McGinigle, K. L., Chisci, E., Clavijo, L. C., Kayssi, A., Schneider, P. A., Hawkins, B. M., Dake, M. D., Hamza, T., Strong, M. B., Rosenfield, K., & Conte, M. S. (2024). The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2024.07.085

Vancouver

Menard MT, Farber A, Doros G, McGinigle KL, Chisci E, Clavijo LC, et al. The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial. Journal of Vascular Surgery. 2024. doi:10.1016/j.jvs.2024.07.085

BibTeX
@article{Menard2024,
  author = {Menard, Matthew T and Farber, Alik and Doros, Gheorghe and McGinigle, Katherine L and Chisci, Emiliano and Clavijo, Leonardo C and Kayssi, Ahmed and Schneider, Peter A and Hawkins, Beau M and Dake, Michael D and Hamza, Taye and Strong, Michael B and Rosenfield, Kenneth and Conte, Michael S},
  title = {The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial},
  journal = {Journal of Vascular Surgery},
  year = {2024},
  doi = {10.1016/j.jvs.2024.07.085}
}
Kostenlos starten →